{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:33:07Z","timestamp":1793824387319,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Medical and Health Research Project of Zhejiang Province","award":["No. 2020KY411"],"award-info":[{"award-number":["No. 2020KY411"]}]},{"name":"the Medical and Health Research Project of Zhejiang Province","award":["No. 2021KY460"],"award-info":[{"award-number":["No. 2021KY460"]}]},{"name":"the Medical and Health Research Project of Zhejiang Province","award":["No. 2022KY019"],"award-info":[{"award-number":["No. 2022KY019"]}]},{"name":"the Scientific Research Project of Department of Education of Zhejiang Provincial","award":["No. Y20204440"],"award-info":[{"award-number":["No. Y20204440"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81800507"],"award-info":[{"award-number":["No. 81800507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03632-5","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:48:49Z","timestamp":1738262929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK\/SIRT1 signaling pathways"],"prefix":"10.1186","volume":"25","author":[{"given":"Chengan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"3","key":"3632_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jhep.2023.04.035","volume":"79","author":"JV Lazarus","year":"2023","unstructured":"Lazarus JV, et al. A global research priority agenda to advance public health responses to fatty liver disease. J Hepatol. 2023;79(3):618\u201334. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.035.","journal-title":"J Hepatol"},{"issue":"1","key":"3632_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s2468-1253(20)30294-6","volume":"6","author":"G Shiha","year":"2021","unstructured":"Shiha G, et al. Redefining fatty liver disease: an international patient perspective. Lancet Gastroenterol Hepatol. 2021;6(1):73\u20139. https:\/\/doi.org\/10.1016\/s2468-1253(20)30294-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"27","key":"3632_CR3","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","volume":"24","author":"YL Fang","year":"2018","unstructured":"Fang YL, et al. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from two hit theory to multiple hit model. World J Gastroenterol. 2018;24(27):2974\u201383. https:\/\/doi.org\/10.3748\/wjg.v24.i27.2974.","journal-title":"World J Gastroenterol"},{"key":"3632_CR4","doi-asserted-by":"publisher","first-page":"117990","DOI":"10.1016\/j.lfs.2020.117990","volume":"256","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, et al. Combination of luteolin and lycopene effectively protect against the two-hit in NAFLD through Sirt1\/AMPK signal pathway. Life Sci. 2020;256:117990. https:\/\/doi.org\/10.1016\/j.lfs.2020.117990.","journal-title":"Life Sci"},{"key":"3632_CR5","doi-asserted-by":"publisher","first-page":"121185","DOI":"10.1016\/j.lfs.2022.121185","volume":"312","author":"R Khairnar","year":"2023","unstructured":"Khairnar R, et al. Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics. Life Sci. 2023;312:121185. https:\/\/doi.org\/10.1016\/j.lfs.2022.121185.","journal-title":"Life Sci"},{"issue":"3","key":"3632_CR6","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1080\/15548627.2022.2110728","volume":"19","author":"Y Qin","year":"2023","unstructured":"Qin Y, Qiu D, Zhang Q. HNF1A regulates the crosstalk between innate immune responses and MAFLD by mediating autophagic degradation of TBK1. Autophagy. 2023;19(3):1026\u20137. https:\/\/doi.org\/10.1080\/15548627.2022.2110728.","journal-title":"Autophagy"},{"issue":"1","key":"3632_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12967-023-04367-1","volume":"21","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, et al. Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy. J Transl Med. 2023;21(1):510. https:\/\/doi.org\/10.1186\/s12967-023-04367-1.","journal-title":"J Transl Med"},{"issue":"12","key":"3632_CR8","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/cvr\/cvad102","volume":"119","author":"K Yang","year":"2023","unstructured":"Yang K, et al. Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress. Cardiovasc Res. 2023;119(12):2190\u2013201. https:\/\/doi.org\/10.1093\/cvr\/cvad102.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"3632_CR9","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jhep.2017.08.010","volume":"67","author":"K Nakamura","year":"2017","unstructured":"Nakamura K, et al. Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury. J Hepatol. 2017;67(6):1232\u201342. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.010.","journal-title":"J Hepatol"},{"key":"3632_CR10","doi-asserted-by":"publisher","unstructured":"Zhang L, et al. Leucine supplementation: a Novel Strategy for modulating lipid metabolism and Energy Homeostasis. Nutrients. 2020;12(5). https:\/\/doi.org\/10.3390\/nu12051299.","DOI":"10.3390\/nu12051299"},{"key":"3632_CR11","doi-asserted-by":"publisher","first-page":"116840","DOI":"10.1016\/j.envpol.2021.116840","volume":"278","author":"X Duan","year":"2021","unstructured":"Duan X, et al. Perfluorooctane sulfonate continual exposure impairs glucose-stimulated insulin secretion via SIRT1-induced upregulation of UCP2 expression. Environ Pollut. 2021;278:116840. https:\/\/doi.org\/10.1016\/j.envpol.2021.116840.","journal-title":"Environ Pollut"},{"issue":"1","key":"3632_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-023-01969-y","volume":"22","author":"M Yang","year":"2023","unstructured":"Yang M, et al. Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation. Lipids Health Dis. 2023;22(1):202. https:\/\/doi.org\/10.1186\/s12944-023-01969-y.","journal-title":"Lipids Health Dis"},{"key":"3632_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.phrs.2018.03.017","volume":"131","author":"H Yao","year":"2018","unstructured":"Yao H, et al. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1\/AMPK signaling pathway. Pharmacol Res. 2018;131:51\u201360. https:\/\/doi.org\/10.1016\/j.phrs.2018.03.017.","journal-title":"Pharmacol Res"},{"issue":"3","key":"3632_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3892\/ijmm.2019.4059","volume":"43","author":"W Zhang","year":"2019","unstructured":"Zhang W, et al. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPAR\u03b1\/FoxO1 signaling pathway. Int J Mol Med. 2019;43(3):1271\u201380. https:\/\/doi.org\/10.3892\/ijmm.2019.4059.","journal-title":"Int J Mol Med"},{"issue":"1","key":"3632_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1186\/s12967-023-04790-4","volume":"21","author":"JW Yang","year":"2023","unstructured":"Yang JW, et al. Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis. J Transl Med. 2023;21(1):921. https:\/\/doi.org\/10.1186\/s12967-023-04790-4.","journal-title":"J Transl Med"},{"issue":"1\u20132","key":"3632_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11010-016-2807-x","volume":"422","author":"Y Tian","year":"2016","unstructured":"Tian Y, et al. Resveratrol supplement inhibited the NF-\u03baB inflammation pathway through activating AMPK\u03b1-SIRT1 pathway in mice with fatty liver. Mol Cell Biochem. 2016;422(1\u20132):75\u201384. https:\/\/doi.org\/10.1007\/s11010-016-2807-x.","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"3632_CR17","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/s11427-016-9027-6","volume":"60","author":"C Geng","year":"2017","unstructured":"Geng C, et al. Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1. Sci China Life Sci. 2017;60(11):1234\u201341. https:\/\/doi.org\/10.1007\/s11427-016-9027-6.","journal-title":"Sci China Life Sci"},{"issue":"3","key":"3632_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/cne.24762","volume":"528","author":"SF Grieco","year":"2020","unstructured":"Grieco SF, et al. Neuregulin and ErbB expression is regulated by development and sensory experience in mouse visual cortex. J Comp Neurol. 2020;528(3):419\u201332. https:\/\/doi.org\/10.1002\/cne.24762.","journal-title":"J Comp Neurol"},{"key":"3632_CR19","doi-asserted-by":"publisher","unstructured":"Ennequin G, et al. Neuregulin 1 improves glucose tolerance in db\/db mice. PLoS ONE. 2015;10(7). https:\/\/doi.org\/10.1371\/journal.pone.0130568.","DOI":"10.1371\/journal.pone.0130568"},{"issue":"2","key":"3632_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.diabet.2015.08.003","volume":"42","author":"K Caillaud","year":"2016","unstructured":"Caillaud K, et al. Neuregulin 1 improves glucose tolerance in adult and old rats. Diabetes Metab. 2016;42(2):96\u2013104. https:\/\/doi.org\/10.1016\/j.diabet.2015.08.003.","journal-title":"Diabetes Metab"},{"issue":"2","key":"3632_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.orcp.2021.01.003","volume":"15","author":"D Meng","year":"2021","unstructured":"Meng D, et al. Roles and mechanisms of NRG1 in modulating the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes (NRG1 modulates NAFLD through ErbB3 signaling). Obes Res Clin Pract. 2021;15(2):145\u201351. https:\/\/doi.org\/10.1016\/j.orcp.2021.01.003.","journal-title":"Obes Res Clin Pract"},{"issue":"9","key":"3632_CR22","doi-asserted-by":"publisher","first-page":"e0137337","DOI":"10.1371\/journal.pone.0137337","volume":"10","author":"A Gu","year":"2015","unstructured":"Gu A, et al. RhNRG-1\u03b2 protects the myocardium against Irradiation-Induced damage via the ErbB2-ERK-SIRT1 signaling pathway. PLoS ONE. 2015;10(9):e0137337. https:\/\/doi.org\/10.1371\/journal.pone.0137337.","journal-title":"PLoS ONE"},{"key":"3632_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jare.2022.08.006","volume":"47","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, et al. ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2\/ERK signaling pathways. J Adv Res. 2023;47:41\u201356. https:\/\/doi.org\/10.1016\/j.jare.2022.08.006.","journal-title":"J Adv Res"},{"key":"3632_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.redox.2018.07.011","volume":"18","author":"R Li","year":"2018","unstructured":"Li R, et al. Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: the role of the ERK-CREB pathway and Bnip3-mediated mitophagy. Redox Biol. 2018;18:229\u201343. https:\/\/doi.org\/10.1016\/j.redox.2018.07.011.","journal-title":"Redox Biol"},{"key":"3632_CR25","doi-asserted-by":"publisher","first-page":"628143","DOI":"10.3389\/fcell.2021.628143","volume":"9","author":"D Jiang","year":"2021","unstructured":"Jiang D, et al. Prolyl Endopeptidase Gene disruption improves gut dysbiosis and non-alcoholic fatty liver disease in mice Induced by a high-Fat Diet. Front Cell Dev Biol. 2021;9:628143. https:\/\/doi.org\/10.3389\/fcell.2021.628143.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3632_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","volume":"21","author":"G Feng","year":"2024","unstructured":"Feng G, et al. Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2024;21(1):46\u201356. https:\/\/doi.org\/10.1038\/s41575-023-00846-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"3632_CR27","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, et al. The Asian Pacific Association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889\u2013919. https:\/\/doi.org\/10.1007\/s12072-020-10094-2.","journal-title":"Hepatol Int"},{"issue":"2","key":"3632_CR28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.gendis.2023.03.021","volume":"11","author":"M Chen","year":"2024","unstructured":"Chen M, et al. The journey towards physiology and pathology: tracing the path of neuregulin 4. Genes Dis. 2024;11(2):687\u2013700. https:\/\/doi.org\/10.1016\/j.gendis.2023.03.021.","journal-title":"Genes Dis"},{"key":"3632_CR29","doi-asserted-by":"publisher","first-page":"26242","DOI":"10.1038\/srep26242","volume":"6","author":"Y Ma","year":"2016","unstructured":"Ma Y, Gao M, Liu D. Preventing high Fat Diet-induced obesity and improving insulin sensitivity through Neuregulin 4 Gene Transfer. Sci Rep. 2016;6:26242. https:\/\/doi.org\/10.1038\/srep26242.","journal-title":"Sci Rep"},{"issue":"12","key":"3632_CR30","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.metabol.2015.08.013","volume":"64","author":"YN Dai","year":"2015","unstructured":"Dai YN, et al. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Metabolism. 2015;64(12):1667\u201373. https:\/\/doi.org\/10.1016\/j.metabol.2015.08.013.","journal-title":"Metabolism"},{"issue":"1","key":"3632_CR31","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1038\/s41598-020-63357-1","volume":"10","author":"CK Gavini","year":"2020","unstructured":"Gavini CK, Bonomo R, Mansuy-Aubert V. Neuronal LXR regulates Neuregulin 1 expression and sciatic nerve-Associated Cell Signaling in Western Diet-fed rodents. Sci Rep. 2020;10(1):6396. https:\/\/doi.org\/10.1038\/s41598-020-63357-1.","journal-title":"Sci Rep"},{"key":"3632_CR32","doi-asserted-by":"publisher","first-page":"812032","DOI":"10.3389\/fendo.2022.812032","volume":"13","author":"S Li","year":"2022","unstructured":"Li S, et al. MOTS-c and Exercise restore Cardiac function by activating of NRG1-ErbB signaling in Diabetic rats. Front Endocrinol (Lausanne). 2022;13:812032. https:\/\/doi.org\/10.3389\/fendo.2022.812032.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"3632_CR33","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1113\/jp270026","volume":"593","author":"G Ennequin","year":"2015","unstructured":"Ennequin G, et al. Exercise training and return to a well-balanced diet activate the neuregulin 1\/ErbB pathway in skeletal muscle of obese rats. J Physiol. 2015;593(12):2665\u201377. https:\/\/doi.org\/10.1113\/jp270026.","journal-title":"J Physiol"},{"issue":"3","key":"3632_CR34","doi-asserted-by":"publisher","first-page":"188707","DOI":"10.1016\/j.bbcan.2022.188707","volume":"1877","author":"C Zhang","year":"2022","unstructured":"Zhang C, Mei W, Zeng C. Oncogenic Neuregulin 1 gene (NRG1) fusions in cancer: a potential new therapeutic opportunities. Biochim Biophys Acta Rev Cancer. 2022;1877(3):188707. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188707.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3632_CR35","doi-asserted-by":"publisher","unstructured":"Honkoop H, et al. Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart. Elife. 2019;8DOI. https:\/\/doi.org\/10.7554\/eLife.50163.","DOI":"10.7554\/eLife.50163"},{"issue":"2","key":"3632_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12265-012-9436-x","volume":"6","author":"L Polidoro","year":"2013","unstructured":"Polidoro L, et al. Vitamin D protects human endothelial cells from H\u2082O\u2082 oxidant injury through the Mek\/Erk-Sirt1 axis activation. J Cardiovasc Transl Res. 2013;6(2):221\u201331. https:\/\/doi.org\/10.1007\/s12265-012-9436-x.","journal-title":"J Cardiovasc Transl Res"},{"issue":"3","key":"3632_CR37","doi-asserted-by":"publisher","first-page":"e0045","DOI":"10.1097\/hc9.0000000000000045","volume":"7","author":"S Huang","year":"2023","unstructured":"Huang S, et al. Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1\/2 pathway. Hepatol Commun. 2023;7(3):e0045. https:\/\/doi.org\/10.1097\/hc9.0000000000000045.","journal-title":"Hepatol Commun"},{"issue":"1","key":"3632_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13578-023-01119-y","volume":"13","author":"T Liu","year":"2023","unstructured":"Liu T, et al. Menin orchestrates hepatic glucose and fatty acid uptake via deploying the cellular translocation of SIRT1 and PPAR\u03b3. Cell Biosci. 2023;13(1):175. https:\/\/doi.org\/10.1186\/s13578-023-01119-y.","journal-title":"Cell Biosci"},{"key":"3632_CR39","doi-asserted-by":"publisher","unstructured":"Huang Q, et al. Ginsenoside Rb2 alleviates hepatic lipid Accumulation by restoring Autophagy via induction of Sirt1 and activation of AMPK. Int J Mol Sci. 2017;18(5). https:\/\/doi.org\/10.3390\/ijms18051063.","DOI":"10.3390\/ijms18051063"},{"issue":"13","key":"3632_CR40","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1093\/nar\/gkad504","volume":"51","author":"G Rasti","year":"2023","unstructured":"Rasti G, et al. SIRT1 regulates DNA damage signaling through the PP4 phosphatase complex. Nucleic Acids Res. 2023;51(13):6754\u201369. https:\/\/doi.org\/10.1093\/nar\/gkad504.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"3632_CR41","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/s42255-021-00498-1","volume":"3","author":"DC Levine","year":"2021","unstructured":"Levine DC, et al. NADH inhibition of SIRT1 links energy state to transcription during time-restricted feeding. Nat Metab. 2021;3(12):1621\u201332. https:\/\/doi.org\/10.1038\/s42255-021-00498-1.","journal-title":"Nat Metab"},{"key":"3632_CR42","doi-asserted-by":"publisher","first-page":"111215","DOI":"10.1016\/j.mad.2020.111215","volume":"187","author":"C Chen","year":"2020","unstructured":"Chen C, et al. SIRT1 and aging related signaling pathways. Mech Ageing Dev. 2020;187:111215. https:\/\/doi.org\/10.1016\/j.mad.2020.111215.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"3632_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216. https:\/\/doi.org\/10.1038\/s41392-022-01073-0.","journal-title":"Signal Transduct Target Ther"},{"key":"3632_CR44","doi-asserted-by":"publisher","first-page":"102569","DOI":"10.1016\/j.redox.2022.102569","volume":"59","author":"A Abulikemu","year":"2023","unstructured":"Abulikemu A, et al. Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress. Redox Biol. 2023;59:102569. https:\/\/doi.org\/10.1016\/j.redox.2022.102569.","journal-title":"Redox Biol"},{"issue":"11","key":"3632_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41574-021-00551-9","volume":"17","author":"M Kitada","year":"2021","unstructured":"Kitada M, Koya D. Autophagy in metabolic disease and ageing. Nat Rev Endocrinol. 2021;17(11):647\u201361. https:\/\/doi.org\/10.1038\/s41574-021-00551-9.","journal-title":"Nat Rev Endocrinol"},{"key":"3632_CR46","doi-asserted-by":"publisher","unstructured":"Chen CL, Lin YC. Autophagy Dysregulation in Metabolic Associated fatty liver disease: a New Therapeutic Target. Int J Mol Sci. 2022;23(17). https:\/\/doi.org\/10.3390\/ijms231710055.","DOI":"10.3390\/ijms231710055"},{"issue":"4","key":"3632_CR47","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","volume":"76","author":"E Scorletti","year":"2022","unstructured":"Scorletti E, Carr RM. A new perspective on NAFLD: focusing on lipid droplets. J Hepatol. 2022;76(4):934\u201345. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.009.","journal-title":"J Hepatol"},{"issue":"7","key":"3632_CR48","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/glia.23150","volume":"65","author":"A Alizadeh","year":"2017","unstructured":"Alizadeh A, et al. Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury. Glia. 2017;65(7):1152\u201375. https:\/\/doi.org\/10.1002\/glia.23150.","journal-title":"Glia"},{"issue":"5","key":"3632_CR49","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1021\/acsami.8b19717","volume":"11","author":"W Zai","year":"2019","unstructured":"Zai W, et al. Targeted Interleukin-22 gene delivery in the liver by Polymetformin and Penetratin-based hybrid nanoparticles to treat nonalcoholic fatty liver disease. ACS Appl Mater Interfaces. 2019;11(5):4842\u201357. https:\/\/doi.org\/10.1021\/acsami.8b19717.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"3632_CR50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12974-016-0703-7","volume":"13","author":"LJ Simmons","year":"2016","unstructured":"Simmons LJ, et al. Regulation of inflammatory responses by neuregulin-1 in brain ischemia and microglial cells in vitro involves the NF-kappa B pathway. J Neuroinflammation. 2016;13(1):237. https:\/\/doi.org\/10.1186\/s12974-016-0703-7.","journal-title":"J Neuroinflammation"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03632-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03632-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03632-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:48:55Z","timestamp":1738262935000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03632-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03632-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"8 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest. All institutional and national guidelines for the care and use of laboratory animals were followed. All experiments were performed with the approval of the Animal Care and Use Committee of Hangzhou Medical College (Permit number: 20180035).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}